QL
ANIK icon

Quarry LP’s Anika Therapeutics ANIK Stock Holding History

Quarry LP’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,592
Closed -$15.3K – 1416
2025
Q4 		$15.3K Sell
1,592
-5,966
-79% -$57.1K ﹤0.01% 1170
2025
Q3 		$71K Buy
+7,558
New +$72.2K 0.02% 655
2024
Q4 		– Sell
-764
Closed -$18.9K – 1614
2024
Q3 		$18.9K Buy
+764
New +$19.8K ﹤0.01% 1118
2024
Q2 		– Sell
-29
Closed -$737 – 1784
2024
Q1 		$737 Buy
+29
New +$702 ﹤0.01% 1589

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Quarry LP's ANIK Position: Q1 2026 in Review

Quarry LP sold out of Anika Therapeutics (ANIK) in Q1 2026, closing a stake of 1,592 shares — an estimated $15.3K sold.

Quarry LP first reported a position in ANIK in Q1 2024 and held it in 4 quarters. The position peaked at $71K in Q3 2025. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Quarry LP reported no remaining Anika Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 1,592 Anika Therapeutics shares in Q1 2026, an estimated $15.3K.
  • Quarry LP first reported a position in Anika Therapeutics in Q1 2024 and held it in 4 quarters.
  • Quarry LP's Anika Therapeutics position peaked at $71K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.